Along with acknowledgment of the many advantages of statins, increasing focus has been placed on diminishing benefits and, in some cases, harms of this drug class when used in patients with limited life expectancy. Statins are prescribed for only preventive purposes, without symptomatic benefit to patients. As such, in some circumstances these agents, which have an estimated time until benefit of more than 2 years, depending on the indication and outcome, are not considered useful in patients with limited life expectancy and are even considered futile at the end of life.1
Holmes HM, Todd A. Evidence-Based Deprescribing of Statins in Patients With Advanced Illness. JAMA Intern Med. 2015;175(5):701–702. doi:10.1001/jamainternmed.2015.0328
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: